Navigation Links
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director
Date:1/16/2010

ST. LOUIS, Jan. 7 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company ( KVa/KVb) today announced that IVS Associates, Inc., the inspector of elections retained by the Company, has certified that the votes represented by a written consent of stockholders received by the Company on December 22, 2009 (the "Written Consent") relating to the appointment of a director by certain stockholders (the "Director Changes") are sufficient to approve the matters set forth in the Written Consent.

The Director Changes include the appointment of John Sampson as a director of the Company to fill the vacancy created by the departure of Mr. Kanterman. As previously disclosed on the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on December 15, 2009, Mr. Kanterman resigned as a member of the Board of Directors on December 11, 2009.

A more detailed description of the Written Consent, including a copy thereof, is set forth in the Current Report on Form 8-K the Company filed today with the SEC.

Pursuant to the rules of the SEC, the Company intends to file with the SEC and distribute to the Company's stockholders a Schedule 14C Information Statement to disclose the Director Changes and certain other related information. The Schedule 14C Information Statement must be sent to stockholders at least 20 calendar days prior to the date on which the proposed corporate action becomes effective.

About KV Pharmaceutical Company

KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets, and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The Company markets its technology distinguished products through ETHEX Corporation, a subsidiary that competes with branded products, and Ther-Rx Corporation, the company's branded drug subsidiary. <
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting ... China,s orthopedic instrument industry has ... size rising from 3.28 billion yuan in 2006 to ...
(Date:1/15/2014)... AARP Foundation today announced it has established a ... severe cold weather that has gripped much of the nation. ... need; so to support these emergency relief efforts AARP and ... could mean up to $500,000 in aid. The matching program ...
(Date:1/15/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Trading (OFT) approval condition to the announced tender offer for all ... As a result of the waiver, the transaction is no ... tender offer on January 24, 2014 following the currently scheduled expiration ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) announced today ... Friday, June 17, 2011. At the meeting, shareholders approved the ... to increase the total number of authorized shares and authorized ... Therapeutics, Inc. Headquartered in Seattle, CTI ...
... 17, 2011 Unilife Corporation ("Unilife" or the ... Kathleen Merrigan, the Deputy Secretary of the U.S. Department of ... local business leaders at its facility in York, Pennsylvania. ... (WHBC) under the direction of President Obama. The Winning ...
Cached Medicine Technology:Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders 2Unilife Hosts White House Business Council Meeting 2Unilife Hosts White House Business Council Meeting 3
(Date:4/18/2014)... A new article published online in The ... to religious music is associated with a decrease in ... and sense of control over their lives. In particular, ... in anxiety about death and an increase in sense ... and whites, women and men, and individuals of both ...
(Date:4/18/2014)... 2014) Benaroya Research Institute at Virginia Mason (BRI) ... particular molecule in metastatic breast cancer reduces both the ... metastases. BRI scientists have found in models of the ... 60 - 80 percent and can keep the tumor ... million five-year grant comes from the National Cancer Institute ...
(Date:4/18/2014)... A discovery by Northwestern Medicine scientists could lead to ... scarring in people with scleroderma. , Fibrosis, or ... tightening of the skin and lungs can lead to ... The concept for new therapeutic options centers on findings ... Medicine-Rheumatology, who identified the role that a specific protein ...
(Date:4/17/2014)... targets that could be used to provide relief ... London made the discovery when researching how pain ... body. , Dr Marzia Malcangio said: "We have ... and our findings could help chemotherapy patients who ... side effect of some chemotherapy drugs (such as ...
(Date:4/17/2014)... Diego School of Medicine report that older women, plucky ... loss are more likely to be compassionate toward strangers ... in this month,s issue of the International Journal ... associated with better health and well-being as we age, ... the outcomes of individuals whose deficits in compassion put ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2
... YORK, Feb. 12 Medicare now pays for treatments ... change that and apply a cost-effectiveness standard set by ... Effectiveness Research.The Federal Council is modeled after a U.K. ... This British board approves or rejects treatments using ...
... damage, and study says it,s likely all that sugar , , THURSDAY, ... cans of soda pop daily are almost two times more likely ... to a U.S. study. , But there,s no increased risk for ... drink diet soda. , The researchers analyzed data from 9,358 adults ...
... The Final Inch and Slumdog Millionaire show the challenges ... Astute Oscar-watchers are getting a short ... nominated films that together show the status of this ... four countries where the virus has not been stopped. ...
... ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced it ... 19, 2009, and will host a conference call to discuss these ... , , , Date: Thursday, February ... Conference call access:, Internet: www.istavision.com, ...
... got radiation treatment for Hodgkin,s disease are almost 40 times ... findings from five institutions, including the University of Florida. ... researchers report. These women are also likely to develop cancer ... get rid of the cancer. Our second priority is to ...
... Pamper Tired TootsiesBETHESDA, Md., Feb. 12 Valentine,s Day marks ... men and women. While the old adage "a way to ... true, another body part is gaining affection from both sexes ... (APMA) survey revealed 84 percent of women are embarrassed about ...
Cached Medicine News:Health News:2 or More Sodas a Day Boost Women's Kidney Risks 2Health News:Oscar Nominated Films Raise Polio Awareness 2Health News:Pediatric Hodgkin's disease survivors face increased breast cancer risk 2Health News:Pediatric Hodgkin's disease survivors face increased breast cancer risk 3Health News:American Podiatric Medical Association Helps Americans 'Love' Their Feet This Valentine's Day 2Health News:American Podiatric Medical Association Helps Americans 'Love' Their Feet This Valentine's Day 3
... Excaliburplus PC, 100V, 50Hz/60Hz is the most ... V PTP in spray Coag. It is the ... power settings from the surgical field with a ... Output Voltage in CUT maintains minimum necessary voltage ...
Microprocessor-based isolated electrosurgical generator, designed for all general surgical procedures. Unit includes the Valleylab adaptive REM system and Instant Response technology....
Black multi-pinhole occluder...
6 inch hand held occlcuder with 49 holes...
Medicine Products: